Formic Acid Wart Composition with Alkyl Esters
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for warts using formic acid are often painful, foul-smelling, and require preparatory steps like scraping or puncturing, with low efficacy and potential for side effects, especially when high concentrations are used.
Innovation Solution
A composition combining formic acid with C1-C4 alkyl esters of lactic acid, malic acid, tartaric acid, or citric acid, such as ethyl lactate, which reduces surface tension and allows for easier application and absorption, eliminating the need for pre-treatment and minimizing discomfort, while maintaining antiviral effectiveness.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If high concentrations of formic acid are used for wart treatment, then efficacy is improved, but pain and side effects increase
Solution Approach 1:
The patent introduces an intermediary substance (alkyl ester of lactic acid, malic acid, tartaric acid, or citric acid) that mediates between the formic acid and the wart tissue. This intermediary reduces the harmful effects (pain, irritation) while maintaining the antiviral efficacy of formic acid, effectively resolving the contradiction between strength and tolerance.
Solution Approach 2:
The patent changes the physical-chemical parameters of the formic acid solution by adding alkyl esters, which alter the surface tension, viscosity, and penetration characteristics. This allows the use of lower formic acid concentrations while maintaining efficacy, thereby reducing pain and side effects.
2Ease of operation
If traditional formic acid treatment is applied without preparatory steps, then ease of application is improved, but efficacy decreases
Solution Approach 1:
The patent incorporates preparatory action directly into the treatment composition itself. The alkyl ester components pre-condition the skin surface and enhance penetration when applied, eliminating the need for separate preparatory steps like scraping or puncturing while maintaining high efficacy.
Solution Approach 2:
The patent merges the preparatory treatment steps with the main treatment in a single combined composition. By combining formic acid with alkyl esters of lactic acid, malic acid, tartaric acid, or citric acid in one formulation, it achieves both ease of application and high efficacy without requiring multiple separate procedures.
3Reliability
If acid-based wart treatment is applied, then antiviral effect is achieved, but discomfort and foul smell occur
Solution Approach 1:
The alkyl ester components act as intermediaries that carry the formic acid to the wart tissue while buffering its harsh effects. This mediation maintains the antiviral action of formic acid while significantly reducing discomfort and eliminating the foul smell associated with traditional acid treatments.
Solution Approach 2:
The patent creates a composite treatment material combining formic acid with multiple alkyl esters (of lactic acid, malic acid, tartaric acid, or citric acid). This composite formulation synergistically combines the antiviral properties of formic acid with the soothing and penetration-enhancing properties of the alkyl esters, achieving effective wart treatment without the harmful side effects of pure acid.
4Reliability
If puncture technique is used to improve formic acid penetration, then efficacy is improved, but device complexity and procedural complexity increase
Solution Approach 1:
The patent replaces the mechanical puncture technique with a chemical solution approach. Instead of using needles or mechanical means to create penetration pathways, the formulation uses alkyl esters to chemically enhance penetration through the stratum corneum, thereby maintaining efficacy while eliminating procedural complexity.
Solution Approach 2:
The alkyl ester components serve as penetrating intermediaries that facilitate formic acid delivery through the skin barrier without mechanical intervention. This chemical mediation achieves effective penetration and wart treatment while avoiding the complexity of puncture techniques and associated devices.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively treats warts with reduced pain and side effects, allowing for daily application and improved patient compliance, with the ability to target both soft and hard warts without the need for puncturing or scraping, and achieving faster wart eradication compared to traditional methods.
Implementation Method 1
the inclusion in the composition of at least one C1-C4 alkyl ester of lactic acid, malic acid, tartaric acid, or citric acid, preferably ethyl lactate, reduces the contact angle of the composition, i.e. reduces the surface tension
Implementation Method 2
Without being bound by any theory, it may be speculated that the number or strengths of hydrogen bonds in the composition is decreased by the inclusion of one of the alkyl esters, such as ethyl lactate, thereby decreasing the contact angle
Data Source
AI summary
The present invention concerns a pharmaceutical composition comprising formic acid and at least one C1-C4 alkyl ester of lactic acid, malic acid, tartaric acid, citric acid, preferably ethyl lactate, for the topical treatment of warts.